Fortrea Holdings Inc and Omico have formed a collaboration to accelerate precision oncology research by connecting cancer patients in Australia to biomarker-matched clinical trials. This partnership combines Fortrea's expertise in oncology clinical trials with Omico's Precision Oncology Screening Platform, PrOSPeCT, to improve trial planning, site selection, and patient recruitment. The initiative aims to expand access to targeted cancer therapies by leveraging genomic profiling and real-world oncology data, enhancing the efficiency of biomarker-driven drug development. This collaboration supports global oncology research and offers more personalized treatment options for patients in Australia.
Fortrea and Omico's collaboration in biomarker-led oncology drug development provides context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 23, 2026 02:41 WIB: Out of 150 priced Health-sector US stocks tradable on Pluang, 77 rose and 71 fell today. Notable movers include Smith & Nephew plc (SNN) at USD 30.84 with a 1-day change of +5.49% and a typical hold time on Pluang of 122 days, Biogen Inc (BIIB) at USD 253.94 with a 1-day change of +5.38% and Pluang order activity showing 2% Sell / 98% Buy with a typical hold time of 111 days, and ImmunityBio Inc. (IBRX) at USD 8.20 with a 1-day change of -5.09% and a typical hold time of 3 days.
Randstad reported revenue and earnings that exceeded expectations, driven by improving business trends and key labor markets. This positive performance signals momentum in the employment services sector. RBC Capital maintained a 'Sector Perform' rati...
MSC Industrial Supply reported strong Q4 results with revenue rising 10.3% year-over-year to about $1.08 billion, surpassing estimates. Adjusted earnings per share increased to $1.45 from $1.09, also beating expectations. Full-year sales grew 6.4% to...
ARMOUR Residential REIT reported a $327 million net loss for Q3 2026, driven by higher interest rates that reduced its book value by 17% to $14.55 per share. Despite the loss, the company earned $83.7 million in net interest income and $102.3 million...
Southern Company, an electric and gas utility, clarified it has no connection to a Mexican silver mining project, dispelling recent rumors. HSBC initiated coverage of Southern Company with a Buy rating, with shares trading at $90.39 at the time. The ...
Remittix is set to add 41 new fiat currencies to its PayFi ecosystem, enhancing crypto-to-bank and bank-to-crypto transactions globally ahead of its November 24 RTX launch. This expansion aims to support more international markets and users, includin...
